stockxa

Valuation-driven analysis for active investors.

News

Quarterly Earnings Review: March 2026 Sees Broad Improvement Across Market Caps

March 2026 earnings data from MarketsMojo shows mid-cap Indian companies posting a 60% positive result rate against just 48% for large-caps — a 12-point spread that warrants scrutiny, not celebration.

Russell Cobb·updated June 30, 2026

Quarterly Earnings Review: March 2026 Sees Broad Improvement Across Market Caps

The India Beat Rate Decomposition

MarketsMojo's quarterly review disaggregates March 2026 results across market-cap tiers. Large-caps delivered a 48.0% positive result rate. Mid-caps hit 60.0%. Small-caps landed at 52.0%. The mid-cap outperformance is the story, but the earnings quality behind it requires examination, not assumption.

Among the named outperformers, Muthoot Finance posted strong NBFC results on improved asset quality and credit demand. Multi Commodity Exchange benefited from higher trading volumes. Puravankara reported sales-driven growth in realty. These are operational results, not balance-sheet miracles — consistent with mid-cap agility capturing sector-specific tailwinds rather than broad macro reflation.

The numbers worth dissecting belong to Vikas Lifecare Ltd. Reported PAT surged 738.1% to ₹41.57 crores versus the prior four-quarter average; PBT excluding other income rose 172.7% to ₹34.39 crores. A 738% jump off a depressed base is optically dramatic but mathematically distinct from organic earnings power. Net sales grew 44.8% to ₹168.62 crores — solid, yet the PAT-to-sales ratio demands a normalised view before any multiple is assigned. The company's internal score moved from -12 to 10 over three months. Score mechanics are not cash flow.

Forward Expectations vs. Delivered Reality

The Investing.com framing matters: if forward S&P 500 EPS growth expectations are unsustainable, the Q2 setup carries asymmetric downside risk. GuruFocus notes Nvidia enters reporting with elevated expectations — and Nvidia's prints historically recalibrate sector multiples regardless of individual beats.

The structural problem is consistency. India delivered mid-cap beats at 60%, yet US forward consensus appears to price in beat rates closer to historical maxima. When expected beats exceed typical delivery rates, the compounding math works against holders, not against sellers. MSN's "sky-high expectations" framing reinforces the same risk surface.

What to Track

Two data points deserve monitoring. First, Vikas Lifecare's stock turned bearish at ₹1.46 on 25 June 2026 per MarketsMojo data — a negative technical signal following a reported 738% PAT surge. That structural contradiction resolves one direction or the other; the price action will confirm whether the earnings beat had multiple-expansion capacity or was already discounted.

Second, the gap between Muthoot Finance's reported asset quality improvement and any forward guidance commentary. NBFC earnings are sensitive to credit cost assumptions; a single quarter of improvement does not constitute a regime change in provisioning norms.

The core analytical task: separate beat rate from earnings power, and separate earnings power from forward multiple sustainability. The Indian data suggests the first separation is doable. The US setup suggests the second may be where the risk concentrates.